Drug
Dapagliflozin Propanediol
Dapagliflozin Propanediol: highest development phase Phase 3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dapagliflozin propanediol (FORXIGA™/FARXIGA™1) NCT05764057 | Phase 3 | AMI |
Latest
No recent events.
Follow Dapagliflozin Propanediol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.